Skip to main content

Canon BioMedical's Novallele Genotyping Assays

Canon BioMedical has launched eleven new genotyping assays. The new assays complement the company's existing 32 assays that target important genes in the CYP family and are part of the 75 Novallele genotyping assays offered by the company that are able to detect variants relevant to pharmacogenetics research. The Novallele assays detect genetic variations using PCR followed by high-resolution melting (HRM) analysis on any thermocycler capable of HRM. The company noted that these assays can not only identify variations in the CYP family, but can also identify variations in the VKORC1, SLC6A4, and DPYD genes.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.